Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02275507 · ClinicalTrials.gov registry record
Non-Invasive Hemoglobin Monitoring of Women Undergoing Cesarean Delivery
A clinical trial, sponsored by Stony Brook University.
- Completed
- Registry status
- 50
- Enrollment target
NCT02275507: Completed study, sponsored by Stony Brook University.
NCT02275507 is a clinical trial that has completed, run by Stony Brook University. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02275507 has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the normal hemoglobin curve during cesarean delivery and for the first 24 hours after surgery to aid in the creation of an algorithm to detect life-threatening bleeding earlier.
Interventions
- DEVICE Masimo Rainbow Sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2014-10-15 |
| Est. Completion | 2016-10-30 |
What the finished NCT02275507 record still lists
NCT02275507 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Masimo Rainbow Sensor is the first listed.
NCT02275507 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02275507 about?
NCT02275507 is a clinical study titled "Non-Invasive Hemoglobin Monitoring of Women Undergoing Cesarean Delivery". The purpose of this study is to determine the normal hemoglobin curve during cesarean delivery and for the first 24 hours after surgery to aid in the creation of an algorithm to detect life-threatening bleeding earlier.
What is the current status of trial NCT02275507?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2014-10-15. Estimated completion is 2016-10-30.
What interventions are being tested in trial NCT02275507?
The interventions under investigation include: Masimo Rainbow Sensor (DEVICE).
Who is sponsoring clinical trial NCT02275507?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI